FDA authorizes a 2nd easy-to-use COVID treatment, Merck's antiviral pill
Published
The Food and Drug Administration has granted Emergency Use Authorization to a second COVID-19 antiviral therapy. This one comes from drug maker Merck.
Full ArticlePublished
The Food and Drug Administration has granted Emergency Use Authorization to a second COVID-19 antiviral therapy. This one comes from drug maker Merck.
Full ArticleThe Food and Drug Administration (FDA) recently authorized two antiviral pills, one from Pfizer and one from Merck, making them the..
The medicine, called molnupiravir, is taken twice a day for five days and works by preventing the virus from replicating. Merck..